Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44])

The summary for the Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44]): -This Funding Opportunity Announcement (FOA) will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, RFA-HG-06-019, that solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms, and RFA-HG-06-015, RFA-HG-06-016, RFA-HG-06-017 that solicit R01, R21 and R21/R33 grant mechanisms. The FOAs solicit applications to develop novel technologies that will substantially reduce the cost of genomic DNA sequencing. Current technologies are able to produce the sequence of a mammalian-sized genome of the desired data quality for $5 to $10 million; the goal of this initiative is to reduce costs by at least two orders of magnitude. As some technologies that have potential to achieve this goal are already in or near the commercial market, applications to this FOA will need to show clear advantage over current and emerging technologies. -Applicants may propose to develop full-scale sequencing systems, or to investigate key components of such systems. Such independent proposals are an important path for pursuing novel, high risk/high pay-off ideas. -Related FOAs (RFA-HG-06-020, RFA-HG-06-021, RFA-HG-06-022, RFA-HG-06-023, RFA-HG-06-024) use the same grant mechanisms to solicit grant applications to reduce genomic DNA sequencing costs by four orders of magnitude.
Federal Grant Title: Near-Term Technology Development for Genome Sequencing (SBIR [R43/R44])
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HG-06-018
Type of Funding: Grant
CFDA Numbers: 93.17293.242
CFDA Descriptions: Human Genome Research 93.242 Mental Health Research Grants
Current Application Deadline: No deadline provided
Original Application Deadline: Nov 25, 2006
Posted Date: Sep 29, 2006
Creation Date: Sep 29, 2006
Archive Date: Dec 25, 2006
Total Program Funding: $2,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply. The NIH will accept as many "different" applications as the applicant organization chooses. However, the NIH will not accept similar grant applications with essentially the same research focus from the same applicant organization. This includes derivative or multiple applications that propose to develop a single product, process or service that, with non-substantive modifications, can be applied to a variety of purposes. Applicants may not simultaneously submit identical/essentially identical applications under both this funding opportunity and any other HHS FOA, including the current SBIR or STTR Parent FOAs .
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster